Brian Casey and Wayne Forrest[email protected]Clinical NewsPull linear MRI contrast from market, European group saysIn a stunning development, a European Union regulatory body on Friday recommended that four gadolinium-based contrast agents for MRI scans be pulled off the market due to concerns about gadolinium remaining in the body years after scans occur. The agents affected include some of the most widely used contrast products in medical imaging.March 9, 2017Page 1 of 1Top StoriesMolecular ImagingPSMA-PET effective for initial staging of prostate cancerResearchers from Bonn, Germany, have found that upfront PSMA-PET/CT has a major impact on treatment decision-making in suspected cases of prostate cancer.UltrasoundGastric ultrasound can be used by novice examinersDigital X-Ray'The disease of kings' comes under intense scrutinyMRIfMRI exams of soccer fans' brains offer clues to the cause of fanaticismSponsor ContentRevolutionizing Thyroid Imaging with DeepHealth AI